Glaukos Corporation (GKOS)
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
Uxin Highlights Operational Strength and Long-Term Growth Strategy at 2026 Investor Day
Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power
Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani
e‑STORAGE to Deliver 426 MWh of Energy Storage in Florida
Nuvation Bio Announces Proposed Convertible Senior Notes Offering
Yiren Digital Reports First Quarter 2026 Unaudited Financial Results
Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor
IsoEnergy Completes Acquisition of Toro Energy
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026